Stockscreener 앱 받기
2.04
6.81%
0.13
시장 영업 전:
1.99
-0.05
-2.45%
전일 마감가:
$1.91
열려 있는:
$1.86
하루 거래량:
141.70K
Relative Volume:
0.05
시가총액:
$30.59M
수익:
$130.00K
순이익/손실:
$-21.29M
주가수익비율:
-1.0319
EPS:
-1.977
순현금흐름:
$-18.29M
1주 성능:
+15.25%
1개월 성능:
+24.39%
6개월 성능:
-30.14%
1년 성능:
-64.58%
1일 변동 폭
$1.835
$2.10
1주일 범위
$1.71
$2.10
52주 변동 폭
$1.22
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
명칭
Serina Therapeutics Inc
전화
(256) 327-9630
주소
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.04 | 28.65M | 130.00K | -21.29M | -18.29M | -1.977 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
Serina Therapeutics Inc 주식(SER)의 최신 뉴스
Insider Buying: Karen Wilson Acquires Shares of Serina Therapeutics Inc (SER) - GuruFocus
Serina Therapeutics director Karen Wilson buys $17,749 common stock By Investing.com - Investing.com India
Serina Therapeutics director Karen Wilson buys $17,749 common stock - Investing.com UK
Director Karen J. Wilson boosts Serina (SER) stake with 10,100-share purchase - Stock Titan
Serina Therapeutics Inc. (SER) Q1 2026 Earnings: Losses Wider Than Expected as Pre-Revenue Biotech Continues Clinical DevelopmentFinal Results - newsline.com
Serina Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView
Serina Therapeutics (SER) Stock Price, News & Analysis $SER - MarketBeat
Serina Therapeutics (SER) Gains 4% as It Tests Key Resistance at $1.90BPI Bull Confirmed - newsline.com
Serina Therapeutics (SER) Tests Key Support After Modest DeclineDealer Delta - newsline.com
SER Q1 2026 Earnings: EPS Misses Estimates as Development-Focused Biotechnology Firm Continues Pipeline ProgressEarnings Revision Upgrade - newsline.com
SER News | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
[EFFECT] Serina Therapeutics, Inc. SEC Filing - Stock Titan
Serina Therapeutics (SER) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Company Reports Wider Loss - thelegaladvocate.com
Serina Therapeutics Inc. Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Navigates Development CostsEarnings Volatility Report - The Legal Advocate
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Serina Therapeutics (SER) grants CEO 10,100 common shares - Stock Titan
Serina Therapeutics (SER) SVP granted 85,558 stock options at $1.89 - Stock Titan
Serina Therapeutics (SER) CEO awarded 380,825 stock options - Stock Titan
Serina Therapeutics (SER) CFO awarded 123,019 stock options at $1.89 - Stock Titan
Serina Therapeutics (SER) CSO receives 85,558 stock options at $1.89 strike - Stock Titan
Serina Therapeutics (SER) Faces Headwinds: Shares Decline 3% Toward Support at $1.82Break of Structure - The Legal Advocate
Serina Therapeutics director Karen Wilson buys $37,000 in shares By Investing.com - Investing.com India
Serina Therapeutics director Karen Wilson buys $37,000 in shares - Investing.com
Director boosts stake in Serina Therapeutics (SER) with 20K-share buy - Stock Titan
Serina Therapeutics (SER) Faces Selling Pressure, Tests Key Support LevelsMAMA Signal - thelegaladvocate.com
Serina Therapeutics (SER) Slips 6% as Stock Approaches Key Support LevelGap Down Bounce Plays - thelegaladvocate.com
Serina Therapeutics Inc (SER) Q1 2026 Earnings: EPS Miss Amid Continued Development ProgressFinancial Summary - Newser
Serina Therapeutics Q1 2026 Earnings: EPS Misses Estimates as Stock Climbs Despite LossGAAP Earnings Report - Newser
Serina Therapeutics Inc. (SER) Recovers 4.93% as Stock Approaches Key Resistance at $2.08Volume Spike Alerts - Newser
Serina Therapeutics Inc. (SER) Gains Nearly 5% as Stock Approaches Key ResistanceTop Analyst Buy Signals - Newser
Director at Serina Therapeutics (SER) makes open-market buy of 12,183 shares - Stock Titan
16.45M Serina shares registered for resale (NYSE: SER) - Stock Titan
Serina Therapeutics : Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi - marketscreener.com
SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
Serina Therapeutics (SER) Gets a Buy from JonesTrading - The Globe and Mail
Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks - The Globe and Mail
Serina Therapeutics 1Q Loss/Shr 58c >SER - Moomoo
Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times
Parkinson's drug trial moves ahead as Serina adds $21.2M funding - Stock Titan
Serina Therapeutics (NYSE: SER) raises $21.2M and advances SER-252 trial - Stock Titan
Serina Therapeutics (NYSE: SER) posts Q1 loss and raises $21.2M PIPE amid cash risk - Stock Titan
SER Technical Analysis | Trend, Signals & Chart Patterns | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
Serina Therapeutics Inc (SER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.27%
1.43%
자본화:
|
볼륨(24시간):